|
|
|
|
 |
|
||
|
|||
 |
|
||
 |
 |
 |
|
 |
|
||
 |
|
||
 |
|
||
 |
|
||
 |
|
||
 |
|
||
 |
|
||
 |
|
||
 |
|
||
 |
|
||
 |
|
||
 |
|
||
 |
|
||
 |
|
||
 |
|
||
 |
|
||
 |
|
||
Ception Therapeutics is a biopharmaceutical company focused on the discovery and development of novel products to address areas of unmet medical need.
Ception was founded by experienced pharmaceutical executives in order to develop and commercialize therapeutics in areas of significant unmet medical need.
LATEST NEWS
June 6, 2008
Ception Therapeutics to Participate in the Private Company Forum at the 29th Annual Goldman Sachs Global Healthcare Conference
Read More>>
March 5, 2008
Ception Therapeutics Initiates Phase II/III Clinical Trial for Its Lead Product Reslizumab in Eosinophilic Esophagitis (EE) in Children
Read More>>
May 31 , 2007
Ception Therapeutics Raises Additional $14.7 Million Bringing Total Series C Financing to $77 Million
Read More>>
